The overall objective is to test the hypothesis that postischemic myocardial dysfunction (myocardial """"""""stunning"""""""") is caused by oxygen- derived free radicals, and to develop potentially useful antioxidant therapies. The oxy-radical hypothesis will be directly investigated by in vivo detection and quantification of free radicals with spin traps and electron paramagnetic resonance (EPR) spectroscopy. A comprehensive, in-depth analysis will be performed by using different spin traps with complementary properties [OBN, (MO)3 PBN, DMPO, 4-POBN] and a new generation of spin traps with unique diagnostic potential (14 C-labeled PBN, deuterated PBN, alpha-13 C PBN, 2,6-Difluoro PBN). The time-course and intensity of radical production will be correlated with the time-course and intensity of contractile dysfunction. Specific scavengers of .O2-, H2O2, or .OH and chelators of iron will be evaluated to determine their ability to suppress radical formation and to identify the most effective antioxidant therapy. To establish whether the radicals produced are responsible for dysfunction, the effects of antioxidants on radical production will be correlated with their effects on recovery of contractility. Antioxidants will be given before ischemia, at reperfusion, or shortly after reperfusion and the results compared to identify the time-window during which the critical radical- mediated damage develops and to determine the optimal time for antioxidant therapy. To elucidate the sources of the injurious radicals, interventions that inhibit neutrophils, autoxidation of catecholamines, and cyclooxygenase will be evaluated. The molecular structure of the radicals will be identified by solvent separation, HPLC, electrochemical detection, EPR spectroscopy, gas chromatography, and mass spectrometry. To test the hypothesis that oxy-radical generation is a common mechanism underlying the entire spectrum of postischemic dysfunction, studies will be performed in three different settings of stunning, i.e., in reversible ischemic insult (15-min coronary occlusion), multiple cumulative ischemic insults (ten 5-min occlusions), or a prolonged ischemic insult associated with subendocardial infarction (980-min occlusion). This proposal should provide important new insights into the mechanism of myocardial stunning. The results should be relevant to several clinical situations in which transient ischemia may precipitate LV dysfunction, namely, unstable or variant angina, cardiopulmonary bypass surgery, cardiac transplantation, and thrombolysis in acute myocardial infarction.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL043151-03
Application #
3361634
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1989-08-01
Project End
1992-12-31
Budget Start
1991-08-01
Budget End
1992-12-31
Support Year
3
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Li, Qianhong; Guo, Yiru; Ou, Qinghui et al. (2009) Gene transfer of inducible nitric oxide synthase affords cardioprotection by upregulating heme oxygenase-1 via a nuclear factor-{kappa}B-dependent pathway. Circulation 120:1222-30
Zuba-Surma, Ewa K; Kucia, Magdalena; Dawn, Buddhadeb et al. (2008) Bone marrow-derived pluripotent very small embryonic-like stem cells (VSELs) are mobilized after acute myocardial infarction. J Mol Cell Cardiol 44:865-73
Wang, Guang-Wu; Guo, Yiru; Vondriska, Thomas M et al. (2008) Acrolein consumption exacerbates myocardial ischemic injury and blocks nitric oxide-induced PKCepsilon signaling and cardioprotection. J Mol Cell Cardiol 44:1016-22
Dawn, Buddhadeb; Xuan, Yu-Ting; Guo, Yiru et al. (2004) IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 64:61-71
Shinmura, Ken; Nagai, Maiko; Tamaki, Kayoko et al. (2004) Gender and aging do not impair opioid-induced late preconditioning in rats. Basic Res Cardiol 99:46-55
Wang, Yang; Kodani, Eitaro; Wang, Jianxun et al. (2004) Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2. Circ Res 95:84-91
Dawn, Buddhadeb; Guo, Yiru; Rezazadeh, Arash et al. (2004) Tumor necrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 37:51-61
Zhang, Jun; Ping, Peipei; Wang, Guang-Wu et al. (2004) Bmx, a member of the Tec family of nonreceptor tyrosine kinases, is a novel participant in pharmacological cardioprotection. Am J Physiol Heart Circ Physiol 287:H2364-6
Tang, Xian-Liang; Xuan, Yu-Ting; Zhu, Yanqing et al. (2004) Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol Heart Circ Physiol 286:H1273-80
Leesar, Massoud A; Stoddard, Marcus F; Xuan, Yu-Ting et al. (2003) Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans. J Am Coll Cardiol 42:437-45

Showing the most recent 10 out of 125 publications